Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.
SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.
For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.
Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.